Skip to content

EFFECT OF AN AYURVEDIC FORMULATION IN PAIN DURING MENSTURATION

MULTICENTRIC OPEN CLINICAL TRIAL OF RAJAHPRAVARTINI VATI IN KASTARTAVA (DYSMENORROHOEA)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005429
Enrollment
360
Registered
2015-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of primary Dysmenorrhoea having painful menstruation for at least 3 consecutive cycles with regular menstrual cycles having normal bleeding phase.

Interventions

Intervention1: Rajahpravartini vati (An Ayurvedic Classical Formulation): Dose - 250 mg. BD, Dosage form - Tablet, Route and time of Administration- Oral at 9.00 am and 9.00 pm after meal, Vehicle -

Sponsors

Central Council For Research In Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Painful menstruation for at least 3 consecutive cycles with regular menstrual cycles having normal bleeding phase. (21-35 days is the normal menstrual cycle) 2. Not associated with any organic Reproductive system abnormalities (Excluded Clinically and Radiological)

Exclusion criteria

Exclusion criteria: 1. Cases of secondary Dysmenorrhoea 2. Pain abdomen associated with excessive Bleeding per vagina 3. Associated with leiomyoma of Uterus, Ovarian Cyst Endometrisis (Radiologically confirmed i.e. USG (ultrasonography) 5. Associated with pelvic inflammatory disease (PID), Hydrosalpinx 6. Associated with any series systemic disorders likely to influence menstrual cycle 7. History of malignancy of pelvic organs 8. History of Hypo and Hyper Thyroidism 9. Woman using an IUD / Oral Contraceptive Pills (OCP) 10. Diabetes mellitus 11. Hypertension

Design outcomes

Primary

MeasureTime frame
Management of pain in the patients of DysmenorrhoeaTimepoint: Baseline, 90 days and 180 days

Secondary

MeasureTime frame
Assessment of Quality of life by using SF36 score.Timepoint: Baseline, 90 days

Countries

India

Contacts

Public ContactDr N Srikanth

Central Council For Research In Ayurvedic Sciences.

sarada_ota@yahoo.com9810425662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026